Viewing Study NCT03338920


Ignite Creation Date: 2025-12-25 @ 4:13 AM
Ignite Modification Date: 2025-12-26 @ 3:12 AM
Study NCT ID: NCT03338920
Status: TERMINATED
Last Update Posted: 2023-07-24
First Post: 2017-11-07
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: Study to Assess the Safety and Efficacy of ONZETRA® Xsail® for the Acute Treatment of Episodic Migraine With or Without Aura in Adolescents
Sponsor: Currax Pharmaceuticals
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2017-11-02
Start Date Type: ACTUAL
Primary Completion Date: 2022-04-11
Primary Completion Date Type: ACTUAL
Completion Date: 2022-04-11
Completion Date Type: ACTUAL
First Submit Date: 2017-11-07
First Submit QC Date: None
Study First Post Date: 2017-11-09
Study First Post Date Type: ACTUAL
Results First Submit Date: 2023-06-13
Results First Submit QC Date: None
Results First Post Date: 2023-07-24
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-07-03
Last Update Post Date: 2023-07-24
Last Update Post Date Type: ACTUAL